Furthermore, mutation of TTN, MUC16, CSMD3, RYR2, and LRP1B were found to be most frequently associated with EGFR/MAP2K1/mTOR/TEAD1/YAP1 alterations in NSCLC (Figure 2G). Here, RYR2 is linked to non-small cell lung carcinoma.